Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Breathnach

Showing results (451-460 of 470) with videos related to

Pageof 47
Sort By:
Thorax|October 24, 2020
Use of exhaled breath condensate (EBC) in the diagnosis of SARS-COV-2 (COVID-19)Daniel J Ryan, Sinead Toomey, Stephen F Madden, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|May 22, 2020
Inter-hospital comparison of Cesarean delivery rates should not be considered to reflect quality of care without consideration of patient heterogeneity: An observational studyNiamh C Murphy, Naomi Burke, Fionnuala M Breathnach, et al.
Lancet (London, England)|October 2, 2018
Awareness of fetal movements and care package to reduce fetal mortality (AFFIRM): a stepped wedge, cluster-randomised trialJane E Norman, Alexander E P Heazell, Aryelly Rodriguez, et al.
Journal of Translational Medicine|May 2, 2021
Targeting the PI3K and MAPK pathways to improve response to HER2-targeted therapies in HER2-positive gastric cancerM Janusz Mezynski, Angela M Farrelly, Mattia Cremona, et al.
Annals of Surgical Oncology|April 5, 2014
The frequencies and clinical implications of mutations in 33 kinase-related genes in locally advanced rectal cancer: a pilot studyKhairun I Abdul-Jalil, Katherine M Sheehan, Sinead Toomey, et al.
Irish Journal of Medical Science|April 11, 2025
CTRIAL-IE (ICORG) 15-34: The impact of the 21 gene breast recurrence score® assay on chemotherapy prescribing in oestrogen receptor positive, lymph node positive early stage breast cancer in IrelandW J Mullally, A Hassan, N Keegan, et al.
Obstetrics and Gynecology|September 4, 2007
First- and second-trimester screening: detection of aneuploidies other than Down syndromeFionnuala M Breathnach, Fergal D Malone, Geralyn Lambert-Messerlian, et al.
NPJ Breast Cancer|September 27, 2023
Predictive modelling of response to neoadjuvant therapy in HER2+ breast cancerNicola Cosgrove, Alex J Eustace, Peter O'Donovan, et al.
Breast Cancer Research : BCR|July 29, 2017
Impact of somatic PI3K pathway and ERBB family mutations on pathological complete response (pCR) in HER2-positive breast cancer patients who received neoadjuvant HER2-targeted therapiesSinead Toomey, Alexander J Eustace, Joanna Fay, et al.
The Journal of Pathology|January 20, 2025
Oronasal mucosal melanoma is defined by two transcriptional subtypes in humans and dogs with implications for diagnosis and therapyKelly L Bowlt Blacklock, Kevin Donnelly, Yuting Lu, et al.
Pageof 47

Showing results (451-460 of 470) with videos related to

Sort By:
Pageof 47
Thorax|October 24, 2020
Use of exhaled breath condensate (EBC) in the diagnosis of SARS-COV-2 (COVID-19)Daniel J Ryan, Sinead Toomey, Stephen F Madden, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|May 22, 2020
Inter-hospital comparison of Cesarean delivery rates should not be considered to reflect quality of care without consideration of patient heterogeneity: An observational studyNiamh C Murphy, Naomi Burke, Fionnuala M Breathnach, et al.
Lancet (London, England)|October 2, 2018
Awareness of fetal movements and care package to reduce fetal mortality (AFFIRM): a stepped wedge, cluster-randomised trialJane E Norman, Alexander E P Heazell, Aryelly Rodriguez, et al.
Journal of Translational Medicine|May 2, 2021
Targeting the PI3K and MAPK pathways to improve response to HER2-targeted therapies in HER2-positive gastric cancerM Janusz Mezynski, Angela M Farrelly, Mattia Cremona, et al.
Annals of Surgical Oncology|April 5, 2014
The frequencies and clinical implications of mutations in 33 kinase-related genes in locally advanced rectal cancer: a pilot studyKhairun I Abdul-Jalil, Katherine M Sheehan, Sinead Toomey, et al.
Irish Journal of Medical Science|April 11, 2025
CTRIAL-IE (ICORG) 15-34: The impact of the 21 gene breast recurrence score® assay on chemotherapy prescribing in oestrogen receptor positive, lymph node positive early stage breast cancer in IrelandW J Mullally, A Hassan, N Keegan, et al.
Obstetrics and Gynecology|September 4, 2007
First- and second-trimester screening: detection of aneuploidies other than Down syndromeFionnuala M Breathnach, Fergal D Malone, Geralyn Lambert-Messerlian, et al.
NPJ Breast Cancer|September 27, 2023
Predictive modelling of response to neoadjuvant therapy in HER2+ breast cancerNicola Cosgrove, Alex J Eustace, Peter O'Donovan, et al.
Breast Cancer Research : BCR|July 29, 2017
Impact of somatic PI3K pathway and ERBB family mutations on pathological complete response (pCR) in HER2-positive breast cancer patients who received neoadjuvant HER2-targeted therapiesSinead Toomey, Alexander J Eustace, Joanna Fay, et al.
The Journal of Pathology|January 20, 2025
Oronasal mucosal melanoma is defined by two transcriptional subtypes in humans and dogs with implications for diagnosis and therapyKelly L Bowlt Blacklock, Kevin Donnelly, Yuting Lu, et al.
Pageof 47